Alvaro
Lassaletta Atienza
Consultor Médico
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublications in collaboration with researchers from University of Texas MD Anderson Cancer Center (2)
2016
-
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
Pediatric Blood and Cancer, Vol. 63, Núm. 10, pp. 1761-1770
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477